查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1485956

全球脊椎侧弯管理市场 - 全球产业分析、规模、占有率、成长、趋势、预测 (2031) - 依产品类型、依年龄层、依分销管道、依地区

Scoliosis Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 273 Pages | 商品交期: 2-5个工作天内

价格
简介目录

由于脊椎侧弯盛行率不断上升以及矫正器技术的进步，全球脊椎侧弯管理市场规模正在显着成长。在现有的各种产品中，颈胸腰骶矫正器（CTLSO）和胸腰骶矫正器（TLSO）对于治疗各种类型的脊椎侧弯非常重要。

CTLSO 支架是两件式结构，带有金属颈椎附件，可支撑颈部和背部并防止脊椎移动。主要用于治疗上背部畸形和颈部问题。当这些支架被移除时，脊椎的弯曲可能会恢復到原来的位置，并随着时间的推移而恶化。

脊椎侧弯在男性中比女性更常见，可分为随着年龄的增长而弯曲消失的脊椎侧弯和脊椎侧弯逐渐进展并需要支架来减缓进展的脊椎侧弯。

青少年脊椎侧弯常见于 5 至 9 岁的儿童。这种类型的脊椎侧弯往往生长迅速且呈进展性，需要使用支架来加强脊椎并减缓弯曲的进展。应每 12 至 18 个月调整一次支架，以适应孩子的成长和曲率变化。

青少年脊椎侧弯发生在 10 至 18 岁之间。确切原因尚不清楚，但被认为是由于荷尔蒙不平衡、生长不对称、肌肉不平衡等造成的。物理治疗和治疗用于10至20度之间的弯曲，支架用于20至40度之间的弯曲以防止进展。为了获得有效的效果，必须在一天中的大部分时间佩戴这些牙套。

本报告调查了全球脊椎侧弯管理市场，并依产品类型、年龄层、分销管道、地区以及进入该市场的公司的竞争趋势提供了市场概述。

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 杵分析

第 3 章2018-2031 年全球脊椎侧弯管理市场展望

  • 2018-2031 年全球脊椎侧弯管理市场展望（依产品类型、价值（十亿美元））
  • 2018-2031 年全球脊椎侧弯管理市场展望（依年龄层）、价值（十亿美元）
  • 2018-2031 年全球脊椎侧弯管理市场展望，依通路划分，价值（十亿美元）
  • 2018-2031 年全球脊椎侧弯管理市场展望（依地区、价值（十亿美元））

第 4 章北美脊椎侧弯管理市场展望，2018-2031

第 5 章欧洲脊椎侧弯管理市场展望，2018-2031

第 6 章亚太地区脊椎侧弯管理市场展望，2018-2031

第 7 章拉丁美洲脊椎侧弯管理市场展望，2018-2031

第 8 章中东与非洲脊椎侧弯管理市场展望，2018-2031 年

第九章竞争态势

  • 2023 年公司市占率分析
  • 竞争仪表板
  • 公司简介
    • Aspen Medical Products
    • DJO Global
    • Ottobock
    • Horton's Orthotics & Prosthetics
    • Boston O&P
    • TRULIFE.
    • Bauerfeind AG
    • Spinal Technology Inc.
    • 其他

第 10 章附录

简介目录

The global scoliosis management market has experienced significant growth due to the increasing prevalence of scoliosis and advancements in brace technology. Among the various products available, Cervical Thoracic Lumbar Sacral Orthosis (CTLSO) and Thoracolumbosacral Orthosis (TLSO) braces are crucial in managing different types of scoliosis.

Key Products in Scoliosis Management

Cervical Thoracic Lumbar Sacral Orthosis (CTLSO) Braces

CTLSO braces are designed with a two-piece structure and a metal cervical attachment that supports the neck and back region, preventing spine movement. They are primarily used to treat upper back deformities and neck issues. If these braces are removed, the spinal curve may return to its original position and could worsen over time.

Thoracolumbosacral Orthosis (TLSO) Braces

TLSO braces are used for the mid to lower spine area. These braces are customized based on the degree of the spinal curve and are prescribed for children with curvature degrees between 20 and 40. The pads in the braces provide pressure to slow down scoliosis progression, allowing for partial movement and accommodating body growth. If the curvature does not increase while wearing the brace, patients can potentially avoid spinal fusion surgery.

Lumbosacral Orthosis (LSO) Braces

LSO braces cover all or part of the lumbar region and are used to correct the lateral curve of the spine. These braces compress the abdomen and lumbar spine tightly, providing posture support to the spine. The pressure applied by the braces can be adjusted through laces or the back of the belt.

Scoliosis Types and Management

Infantile Scoliosis

Infantile scoliosis affects infants between birth and four years of age, presenting as an abnormal curve shaped like an S or C. This condition is more common in males than females and falls into two categories: those whose curvature disappears with growth and those whose curvature progresses and requires bracing to slow its progression.

Juvenile Scoliosis

Juvenile scoliosis is diagnosed in children aged five to nine years. This type of scoliosis tends to grow faster and becomes progressive, necessitating the use of braces to strengthen the spine and restrain curvature progression. Braces need to be adjusted every 12 to 18 months to accommodate the child's growth and changing curvature.

Adolescent Scoliosis

Adolescent scoliosis occurs between the ages of 10 and 18 years. Although the exact cause is unknown, it may be due to hormonal imbalances, asymmetrical growth, and muscle imbalance. Physical therapies and treatments are administered for curves between 10 and 20 degrees, while braces are used for curves between 20 and 40 degrees to prevent progression. These braces need to be worn continuously for most of the day to achieve effective results.

Market Dynamics

Growth Drivers

The global scoliosis management market is primarily driven by the high prevalence of the disease, the widespread adoption of braces, and technological advancements in tracking devices that monitor patient health. Additionally, the increasing demand for non-invasive therapies is expected to drive market growth for scoliosis braces.

Challenges

Despite the growth prospects, several challenges persist. The braces need to be worn for most of the day, which can cause stiffness, skin irritation, and rashes. Additionally, the compression of the chest wall and abdomen can lead to breathing problems, affecting oxygen flow and pulmonary functions.

Market Outlook

The global scoliosis management market is expected to continue growing, driven by less expensive braces and increasing awareness among people. These factors are anticipated to further propel market growth over the forecast period.

Key Market Players Include:

  • Aspen Medical Products
  • DJO Global
  • Ottobock
  • Horton's Orthotics & Prosthetics
  • Boston O&P
  • TRULIFE.
  • Bauerfeind AG
  • Spinal Technology Inc.
  • Fited
  • Wellinks, Inc.
  • Others.

Global Scoliosis Management Market Segmentation:

By Product Type:

  • Cervical Thoracic Lumbar
  • Thoracolumbosacral orthosis
  • Lumbosacral Orthosis

By Age Group:

  • Infantile Scoliosis
  • Juvenile Scoliosis
  • Adolescent Scoliosis

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online sales

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Scoliosis Management Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. PESTLE Analysis

3. Global Scoliosis Management Market Outlook, 2018 - 2031

  • 3.1. Global Scoliosis Management Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Cervical Thoracic Lumbar
      • 3.1.1.2. Thoracolumbosacral orthosis
      • 3.1.1.3. Lumbosacral Orthosis
  • 3.2. Global Scoliosis Management Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Infantile Scoliosis
      • 3.2.1.2. Juvenile Scoliosis
      • 3.2.1.3. Adolescent Scoliosis
  • 3.3. Global Scoliosis Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospital Pharmacies
      • 3.3.1.2. Retail Pharmacies
      • 3.3.1.3. Online sales
  • 3.4. Global Scoliosis Management Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Scoliosis Management Market Outlook, 2018 - 2031

  • 4.1. North America Scoliosis Management Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Cervical Thoracic Lumbar
      • 4.1.1.2. Thoracolumbosacral orthosis
      • 4.1.1.3. Lumbosacral Orthosis
  • 4.2. North America Scoliosis Management Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Infantile Scoliosis
      • 4.2.1.2. Juvenile Scoliosis
      • 4.2.1.3. Adolescent Scoliosis
  • 4.3. North America Scoliosis Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospital Pharmacies
      • 4.3.1.2. Retail Pharmacies
      • 4.3.1.3. Online sales
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Scoliosis Management Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.4.1.2. U.S. Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 4.4.1.3. U.S. Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 4.4.1.4. Canada Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.4.1.5. Canada Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 4.4.1.6. Canada Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Scoliosis Management Market Outlook, 2018 - 2031

  • 5.1. Europe Scoliosis Management Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Cervical Thoracic Lumbar
      • 5.1.1.2. Thoracolumbosacral orthosis
      • 5.1.1.3. Lumbosacral Orthosis
  • 5.2. Europe Scoliosis Management Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Infantile Scoliosis
      • 5.2.1.2. Juvenile Scoliosis
      • 5.2.1.3. Adolescent Scoliosis
  • 5.3. Europe Scoliosis Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospital Pharmacies
      • 5.3.1.2. Retail Pharmacies
      • 5.3.1.3. Online sales
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Scoliosis Management Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.2. Germany Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 5.4.1.3. Germany Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.4. U.K. Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.5. U.K. Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 5.4.1.6. U.K. Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.7. France Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.8. France Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 5.4.1.9. France Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.10. Italy Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.11. Italy Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 5.4.1.12. Italy Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.13. Turkey Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.14. Turkey Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 5.4.1.15. Turkey Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.16. Russia Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.17. Russia Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 5.4.1.18. Russia Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.19. Rest of Europe Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.20. Rest of Europe Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 5.4.1.21. Rest of Europe Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Scoliosis Management Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Scoliosis Management Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Cervical Thoracic Lumbar
      • 6.1.1.2. Thoracolumbosacral orthosis
      • 6.1.1.3. Lumbosacral Orthosis
  • 6.2. Asia Pacific Scoliosis Management Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Infantile Scoliosis
      • 6.2.1.2. Juvenile Scoliosis
      • 6.2.1.3. Adolescent Scoliosis
  • 6.3. Asia Pacific Scoliosis Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospital Pharmacies
      • 6.3.1.2. Retail Pharmacies
      • 6.3.1.3. Online sales
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Scoliosis Management Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.2. China Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 6.4.1.3. China Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.4. Japan Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.5. Japan Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 6.4.1.6. Japan Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.7. South Korea Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.8. South Korea Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 6.4.1.9. South Korea Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.10. India Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.11. India Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 6.4.1.12. India Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.13. Southeast Asia Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.14. Southeast Asia Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 6.4.1.15. Southeast Asia Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Scoliosis Management Market Outlook, 2018 - 2031

  • 7.1. Latin America Scoliosis Management Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Cervical Thoracic Lumbar
      • 7.1.1.2. Thoracolumbosacral orthosis
      • 7.1.1.3. Lumbosacral Orthosis
  • 7.2. Latin America Scoliosis Management Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
      • 7.2.1.1. Infantile Scoliosis
      • 7.2.1.2. Juvenile Scoliosis
      • 7.2.1.3. Adolescent Scoliosis
  • 7.3. Latin America Scoliosis Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospital Pharmacies
      • 7.3.1.2. Retail Pharmacies
      • 7.3.1.3. Online sales
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Scoliosis Management Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.2. Brazil Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 7.4.1.3. Brazil Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 7.4.1.4. Mexico Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.5. Mexico Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 7.4.1.6. Mexico Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 7.4.1.7. Argentina Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.8. Argentina Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 7.4.1.9. Argentina Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Scoliosis Management Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Scoliosis Management Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Cervical Thoracic Lumbar
      • 8.1.1.2. Thoracolumbosacral orthosis
      • 8.1.1.3. Lumbosacral Orthosis
  • 8.2. Middle East & Africa Scoliosis Management Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Infantile Scoliosis
      • 8.2.1.2. Juvenile Scoliosis
      • 8.2.1.3. Adolescent Scoliosis
  • 8.3. Middle East & Africa Scoliosis Management Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospital Pharmacies
      • 8.3.1.2. Retail Pharmacies
      • 8.3.1.3. Online sales
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Scoliosis Management Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.2. GCC Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 8.4.1.3. GCC Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 8.4.1.4. South Africa Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.5. South Africa Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 8.4.1.6. South Africa Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 8.4.1.7. Egypt Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.8. Egypt Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 8.4.1.9. Egypt Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 8.4.1.10. Nigeria Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.11. Nigeria Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 8.4.1.12. Nigeria Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Scoliosis Management Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Scoliosis Management Market by Age Group, Value (US$ Bn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Scoliosis Management Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Market Share Analysis, 2023
  • 9.2. Competitive Dashboard
  • 9.3. Company Profiles
    • 9.3.1. Aspen Medical Products
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Product Portfolio
      • 9.3.1.3. Financial Overview
      • 9.3.1.4. Business Strategies and Development
    • 9.3.2. DJO Global
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Product Portfolio
      • 9.3.2.3. Financial Overview
      • 9.3.2.4. Business Strategies and Development
    • 9.3.3. Ottobock
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Product Portfolio
      • 9.3.3.3. Financial Overview
      • 9.3.3.4. Business Strategies and Development
    • 9.3.4. Horton's Orthotics & Prosthetics
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Product Portfolio
      • 9.3.4.3. Financial Overview
      • 9.3.4.4. Business Strategies and Development
    • 9.3.5. Boston O&P
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Product Portfolio
      • 9.3.5.3. Financial Overview
      • 9.3.5.4. Business Strategies and Development
    • 9.3.6. TRULIFE.
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Product Portfolio
      • 9.3.6.3. Financial Overview
      • 9.3.6.4. Business Strategies and Development
    • 9.3.7. Bauerfeind AG
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Product Portfolio
      • 9.3.7.3. Financial Overview
      • 9.3.7.4. Business Strategies and Development
    • 9.3.8. Spinal Technology Inc.
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Product Portfolio
      • 9.3.8.3. Financial Overview
      • 9.3.8.4. Business Strategies and Development
    • 9.3.9. Others
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Product Portfolio
      • 9.3.9.3. Financial Overview
      • 9.3.9.4. Business Strategies and Development

10. Appendix

  • 10.1.Research Methodology
  • 10.2.Report Assumptions
  • 10.3.Acronyms and Abbreviations